GDRX Stock Performance, Insider Transaction and News

GDRX - GoodRx Holdings, Inc.

Market Cap	3.36B	P/E	-	EPS this Y	25.00%	Ern Qtrly Grth	-88.60%
Income	-58.68M	Forward P/E	27.29	EPS next Y	25.70%	50D Avg Chg	39.00%
Sales	775.09M	PEG	0.66	EPS past 5Y	-3.93%	200D Avg Chg	55.00%
Dividend	N/A	Price/Book	4.06	EPS next 5Y	30.00%	52W High Chg	-18.00%
Recommedations	2.20	Quick Ratio	7.11	Shares Outstanding	98.58M	52W Low Chg	121.00%
Insider Own	12.42%	ROA	1.88%	Shares Float	82.81M	Beta	1.39
Inst Own	63.49%	ROE	-7.50%	Shares Shorted/Prior	8.95M/8.21M	Price	8.46
Gross Margin	93.07%	Profit Margin	-7.57%	Avg. Volume	1,668,862	Target Price	9.53
Oper. Margin	9.91%	Earnings Date	Nov 7	Volume	2,493,102	Change	-2.42%

Healthcare | Health Information Services | United States

About GoodRx Holdings, Inc.

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

GoodRx Holdings, Inc. News

11/11/24	GoodRx Holdings Third Quarter 2024 Earnings: EPS Misses Expectations
11/08/24	Why GoodRx Holdings Stock Was Sinking This Week
11/08/24	GoodRx Holdings Inc (GDRX) Q3 2024 Earnings Call Highlights: Strong Financial Performance ...
11/07/24	GoodRx (GDRX) Q3 2024 Earnings Call Transcript
11/07/24	GoodRx (GDRX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
11/07/24	GoodRx Holdings, Inc. (GDRX) Misses Q3 Earnings and Revenue Estimates
11/07/24	GoodRx Reports Third Quarter 2024 Results
11/06/24	GoodRx (GDRX) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
11/04/24	GoodRx to Participate in Upcoming Investor Conferences
10/31/24	GoodRx Unveils New E-commerce Platform, Launches with Opill®
10/29/24	GoodRx stock moves on exclusive 30-day offer of weight management drug Qsymia
10/29/24	GoodRx Announces Exclusive Low Cash Price for QSYMIA®, the Leading Branded Once-Daily Oral Weight Management Medication for Adults
10/28/24	Ronald E. Bruehlman Joins GoodRx Board of Directors
10/23/24	GoodRx Announces New Affordability Programs for Menopause Hormone Therapies
10/16/24	GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers
10/10/24	GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call
10/09/24	GoodRx Holdings Inc (GDRX) Q2 2024 Earnings Call Highlights: Revenue Growth Amidst Challenges
10/08/24	ELV vs. GDRX: Which Stock Is the Better Value Option?
10/02/24	High Growth Tech Stocks In The United States To Watch
09/26/24	GoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy® (epinephrine nasal spray)

GDRX Chatroom

tiktokstocks Posted - 9 hours ago

$GDRX

tiktokstocks Posted - 9 hours ago

$GDRX bottomed. Catapult to 6$ soon. $pags $crnc $para. Just sold ebr. Gdrx a better buy.

Xsaif Posted - 1 day ago

$GDRX Added for a swing. Lets go!

StockBraker Posted - 1 day ago

$GDRX I like the constant innovation and efforts to create "stickiness" with their users. I hate the share price trend. Marketing methods for stickiness rewards" primarily refers to strategies like loyalty programs, tiered rewards, personalized offers, and gamification elements that incentivize customers to repeatedly engage with a brand, thus increasing their "stickiness" or likelihood of returning for more purchases and interactions

TheLearnerEarner Posted - 2 days ago

$GDRX ✅ UNDERVALUED stock swing trade - technology - mid cap - 6/9 F-Score - 1.01x relative volume - 2x outperform rating - 6x analysts buy rating - excellent intrinsic value potential - earnings are forecast to grow approx. 47% per year - trading at approx. 72% below estimate of its fair value - short to medium term gains 📈 RSI: 18.64 (oversold heavily) 📊⚓ Analysts Price Target: $7.28 - $16.80 (70% - 297% above Price) 🌟 Range (12m) $4.09 - $9.26 💰 NEWSDESK (last recent article) 📰 https://finance.yahoo.com/news/goodrx-holdings-inc-gdrx-q3-071050158.html

gatormike12 Posted - 3 days ago

$GDRX It's undervalued. It'll go back to $9-$10.

Pitbowl Posted - 3 days ago

$GDRX

BillyBeavers Posted - 3 days ago

$GDRX This trash is a buy....

NSAR Posted - 5 days ago

$GDRX

NSAR Posted - 5 days ago

$GDRX before the election many analyst said that GoodRx would benefit from a Trump win. Hopefully we see that play out right now is following the market until people figure out that if people are more focused on cost, GoodRx is the player

mogambu Posted - 6 days ago

$GDRX crazy how low it can go

Lg24 Posted - 6 days ago

$GDRX RFK Jr nomination spooked the healthcare market

Nosh Posted - 6 days ago

$GDRX Nice...got my entry point...will added when needed.

Xsaif Posted - 6 days ago

$GDRX Wtf is happening?! Somebody enlighten me please.

Lg24 Posted - 6 days ago

$GDRX today should be a buy in …all drug and health stocks plummeting due to RFK nom

PeasantToRich Posted - 6 days ago

$GOSS $GDRX good days to add at these levels

Nosh Posted - 6 days ago

$GDRX Let it come in...I have small starter...but interested.

bossdj Posted - 6 days ago

$GDRX not growing extremely quick, but I see positive things in 2025 for this. May have to buy in now near ATL as they are (very lightly) profitable again.

Cloudburn Posted - 1 week ago

$GDRX excellent buying opportunity here

Luka_Brasi Posted - 1 week ago

$GDRX Aay carumba that's one shitty ALL chart.

PhishTourFunds Posted - 1 week ago

$GDRX

StockBraker Posted - 1 week ago

$GDRX Latest incentive campaign.

anachartanalyst Posted - 1 week ago

$GDRX https://anachart.com/wp-content/uploads/ana_temp/1731337330_soc-img.jpg

PeasantToRich Posted - 1 week ago

$GDRX needs to buy back shares at these levels. They bought back higher. They have 200m+ to use. Use it

PeasantToRich Posted - 1 week ago

$GDRX down 21% for being profitable. Makes sense

StockHunter75 Posted - 1 week ago

$GDRX Adding some

Jbead61 Posted - 1 week ago

$GDRX I don’t care what the streets expectations are, they are managing debt will and their profit margins are improving even with losing Kroger. I have been sinking my gains from others into this stock the last few days just to sit for seven years

PeasantToRich Posted - 1 week ago

$GDRX order flow is reversing.

PeasantToRich Posted - 1 week ago

$GDRX down 42% 3 month. Time for a reversal

ahab Posted - 1 week ago

$GDRX huh?

Analyst Ratings

RBC Capital	Outperform	Aug 16, 24
Citigroup	Buy	Aug 9, 24
UBS	Neutral	Aug 9, 24
Morgan Stanley	Equal-Weight	Jun 10, 24
RBC Capital	Outperform	May 23, 24
Barclays	Overweight	May 20, 24
Raymond James	Outperform	May 16, 24
TD Cowen	Buy	May 16, 24
Keybanc	Overweight	Apr 10, 24

Insider Trades	Relationship	Date	Transactions	Cost($)	#Shares	Value($)	#Share Own	SEC Form 4
Wagner Scott	See Remarks See Remarks	Nov 16	Buy	5.21	130,743	681,171	130,743	11/17/23
Slutsky Andrew	President, Consumer President, Consumer	Mar 18	Option	2.1808	91,667	199,907	2,976,196	03/22/22
Idea Men, LLC	10% Owner 10% Owner	Jan 03	Sell	33.05	2,600	85,930		01/05/22
Voermann Karsten	Chief Financial Offi.. Chief Financial Officer	Nov 01	Option	6.84	12,500	85,500	12,500	11/03/21
Voermann Karsten	Chief Financial Offi.. Chief Financial Officer	Nov 01	Sell	22.02	12,500	275,250		11/03/21
Idea Men, LLC	10% Owner 10% Owner	Nov 01	Sell	43.85	310,198	13,602,182		11/03/21
Slutsky Andrew	President, Consumer President, Consumer	Oct 22	Sell	46.46	20,000	929,200	3,049,529	10/26/21
Azad Babak	See Remarks See Remarks	Oct 11	Option	5.94	7,500	44,550	7,500	10/13/21
Azad Babak	See Remarks See Remarks	Oct 11	Sell	40.91	7,500	306,825		10/13/21
NAGJI BANSI	President, Healthcar.. President, Healthcare	Oct 07	Sell	45.05	3,600	162,180	29,166	10/12/21
NAGJI BANSI	President, Healthcar.. President, Healthcare	Oct 07	Option	6.84	3,600	24,624	32,766	10/12/21
REY-GIRAUD AGNES	Director Director	Sep 16	Sell	45.01	25,000	1,125,250		09/16/21
NAGJI BANSI	President, Healthcar.. President, Healthcare	Sep 16	Sell	45.03	180,000	8,105,400		09/16/21
NAGJI BANSI	President, Healthcar.. President, Healthcare	Sep 16	Option	6.84	180,000	1,231,200	29,788	09/16/21
Azad Babak	See Remarks See Remarks	Sep 14	Sell	41.46	12,500	518,250		09/14/21
Azad Babak	See Remarks See Remarks	Sep 14	Option	5.94	12,500	74,250	12,500	09/14/21
Abdiel Capital Management, LLC	10% Owner 10% Owner	Sep 13	Buy	40.66	3,900	158,574	8,792,967	09/13/21
Abdiel Capital Management, LLC	10% Owner 10% Owner	Sep 08	Buy	40.94	473,133	19,370,065	8,789,067	09/08/21
Abdiel Capital Management, LLC	10% Owner 10% Owner	Sep 02	Buy	37.62	705,396	26,536,998	8,315,934	09/02/21
Voermann Karsten	Chief Financial Offi.. Chief Financial Officer	Jul 30	Option	6.84	12,500	85,500	12,500	07/30/21